Notices. Workshop announcement
7,903 words·~36 min read·
/register/2008/01/03/07-6277A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
BILLING CODE 6715-01-M FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated.
The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than January 18, 2008. **A. Federal Reserve Bank of San Francisco** (Tracy Basinger, Director, Regional and Community Bank Group) 101 Market Street, San Francisco, California 94105-1579: *1. Polamar QFP, LP* , Long Beach, California; to acquire 100 percent of the voting shares of Palomar Enterprises, LLC and thereby indirectly acquire voting shares of Farmers & Merchants Bank of Long Beach, both of Long Beach, California.
Board of Governors of the Federal Reserve System, December 28, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7-25562 Filed 1-2-08; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below.
The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The application also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843).
Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than January 28, 2008. **A. Federal Reserve Bank of Minneapolis** (Jacqueline G.
King, Community Affairs Officer) 90 Hennepin Avenue, Minneapolis, Minnesota 55480-0291: *1. Frandsen Financial Corporation* , Arden Hills, Minnesota; to acquire 100 percent of the voting shares of The First National Bank of Montgomery, Montgomerey, Minnesota. Board of Governors of the Federal Reserve System, December 28, 2007. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E7-25561 Filed 1-2-08; 8:45 am] BILLING CODE 6210-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60 Day-08-08AG] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995 for opportunity for public comment on proposed data collection projects, the Centers for Disease Control and Prevention
(CDC)will publish periodic summaries of proposed projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call 404-639-5960 or send comments to Maryam I. Daneshvar, CDC Reports Clearance Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to *omb@cdc.gov.* Comments are invited on:
(a)Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
(b)the accuracy of the agency's estimate of the burden of the proposed collection of information;
(c)ways to enhance the quality, utility, and clarity of the information to be collected; and
(d)ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology. Written comments should be received within 60 days of this notice. Proposed Project HIV/AIDS Surveillance, Research, and Intervention Methods and Materials Development—New—National Center for HIV, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The Division of HIV/AIDS Prevention
(DHAP)within the National Center for HIV, Hepatitis, STD, and TB Prevention (NCHHSTP) of the Centers for Disease Control and Prevention
(CDC)is planning to request the Office of Management and Budget for a generic clearance mechanism to support behavioral projects. The projects encompass several qualitative analytic methods, intervention, and materials development activities to be carried out by CDC, its contractors, or its partners. The major activities fall into six categories based on their purpose and intended use:
(1)*Qualitative interviewing for HIV/AIDS surveillance, research, and intervention methods and material development.* Results of individual interviews or group interviews are used to develop population-appropriate methods, interventions, and data collection materials for current and future projects.
(2)*Cognitive interviewing for development and testing of specific data collection instruments used for HIV/AIDS surveillance or research.* Draft instruments to be used by DHAP are developed and tested through rounds of cognitive interviews with volunteer respondents. Results of cognitive interviews are used to make instrument design decisions that minimize response error and reduce burden to the public.
(3)*Research on methodology for HIV/AIDS surveillance or research projects.* The purpose of the research is to enhance understanding of the psychology of participation and response, to develop better standards for project methodology and instrument design, or to improve data collection and other study procedures. Such research could take the form of experiments embedded within fielded surveillance or research projects or exploratory studies employing individual interviews or focus groups.
(4)*Research on utilizing computer-assisted instruments (including web-based technology) for HIV surveillance or research projects.* This research uses qualitative and quantitative data collection methods with volunteer respondents in order to assess the design and use of computer-assisted instruments.
(5)*Pilot interviews.* A limited number of pilot interviews are conducted using proposed instruments and data collection methodologies. Sources of response error are identified through examination of pilot data, observation by methodologists, and techniques such as the coding of the interviewer-respondent interaction. Respondents for pilot interviews and interventions will be selected using the methods developed for the study that is being piloted.
(6)*Pilot testing of behavioral interventions.* Component testing will assess acceptability and feasibility of separate intervention activities. A limited number of pilot tests are conducted for behavioral interventions prior to being tested in a “full intervention trial.” Respondents who will participate in individual and group interviews (qualitative, cognitive, and computer-assisted development activities) are selected purposively from those who respond to recruitment advertisements. In addition to utilizing advertisements for recruitment, respondents who will participate in research on survey methods may be selected purposively or systematically from within an ongoing surveillance or research project. CDC estimates that an average of 1430 individuals will participate in HIV/AIDS methods, intervention, and instrument development activities in a given year and the average annual respondent burden is estimated to be 2135 hours. The estimates given below cover the time that each respondent will spend communicating with the recruitment staff, in answering survey questions and, in some cases, being debriefed about the decision and recall strategies they used. Participation of respondents is voluntary and there is no cost to the respondents other than their time. Estimate of Annualized Burden Table Types of data collection No. of respondents No. of responses per respondent Average burden per response (in hours) Total burden (in hours)
(1)Methods, interventions, and materials development—individual interviews 250 1 1 250
(2)Methods, interventions, and materials development—group interviews 450 1 2 900
(3)Research on survey methodology 150 1 1 150
(4)Research on human-computer interface 350 1 1 350
(5)Pilot interviewing 200 1 1 200
(6)Pilot interventions 30 6 2 360 Total 1,430 2,210 Dated: December 26, 2007. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E7-25564 Filed 1-2-08; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Toxicology Program (NTP); NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM); Workshop on Acute Chemical Safety Testing: Advancing In Vitro Approaches and Humane Endpoints for Systemic Toxicity Evaluations AGENCY: National Institute of Environmental Health Sciences (NIEHS), National Institutes of Health (NIH). ACTION: Workshop announcement. SUMMARY: The Interagency Committee on the Validation of Alternative Methods (ICCVAM) and NICEATM announce the upcoming “Scientific Workshop on Acute Chemical Safety Testing: Advancing *In Vitro* Approaches and Humane Endpoints for Systemic Toxicity Evaluations.” The goals of the workshop are to:
(1)Review the state-of-the-science and identify knowledge gaps regarding the key pathways involved in acute systemic toxicity.
(2)Recommend how these knowledge gaps can be addressed by collecting mechanistic biomarker data during currently required *in vivo* safety testing.
(3)Recommend how key *in vivo* pathway information can be used to develop more predictive mechanism-based *in vitro* test systems and earlier, more humane endpoints for *in vivo* test methods.
(4)Recommend how mechanism-based *in vitro* test systems and earlier, more humane endpoints can be used to further reduce, refine, and eventually replace animal use for acute systemic toxicity testing while ensuring the protection of human and animal health. This workshop is open to the public with attendance limited only by the space available. DATES: The workshop will be held on February 6-7, 2008. ADDRESSES: The workshop will be held at the NIH, Natcher Conference Center, 45 Center Drive, Bethesda, MD 20892. A draft agenda and other information are available on the ICCVAM workshop Web site ( *http://iccvam.niehs.nih.gov/meetings/AcuteToxWksp08/AcuteToxWksp08.htm* ) and can be obtained from NICEATM (see FOR FURTHER INFORMATION CONTACT below). FOR FURTHER INFORMATION CONTACT: Dr. William S. Stokes, NICEATM Director, NIEHS, P.O. Box 12233, MD EC-17, Research Triangle Park, NC 27709, (telephone) 919-541-2384,
(fax)919-541-0947, (e-mail) *niceatm@niehs.nih.gov.* SUPPLEMENTARY INFORMATION: Background NICEATM and ICCVAM convened a peer review panel meeting in 2006. The panel was charged to determine the usefulness and limitations of two *in vitro* cytotoxicity test methods for determining starting doses for two acute oral toxicity test methods, the Up-and-Down Procedure and the Acute Toxic Class method, in order to reduce the number of animals used in each of these *in vivo* tests. The panel's conclusions and recommendations are described in the *Peer Review Panel Report: The Use of In Vitro Basal Cytotoxicity Test Methods for Estimating Starting Doses for Acute Oral Systemic Toxicity Testing* (available at *http://iccvam.niehs.nih.gov/methods/acutetox/inv_nru_scpeerrev.htm* ). The panel recommended that ICCVAM consider convening a working group to explore mechanisms of action for acute toxicity and to identify approaches for acquiring additional information on acute toxicity mechanisms when conducting required *in vivo* acute toxicity testing. The Scientific Advisory Committee on Alternative Toxicological Methods (SACATM) met by teleconference on August 3, 2006, and expressed support for the panel's recommendations (minutes of that meeting are available at *http://ntp.niehs.nih.gov/files/SACATMAug06MinutesVF081506.pdf* ). NICEATM and ICCVAM included activities in their draft Five-Year Plan (2008-2012) ( *http://iccvam.niehs.nih.gov/docs/5yearplan.htm* ) to further reduce animal use and potential pain and distress associated with acute toxicity testing. These included organizing an international workshop to
(1)identify predictive and more humane endpoints that may be used to terminate studies earlier in order to further reduce the severity and duration of pain and distress and
(2)identify and standardize procedures for collecting mechanistic information from *in vivo* acute oral toxicity testing that will aid in developing batteries of predictive *in vitro* test methods that can further reduce and eventually replace animals for acute toxicity testing. The ICCVAM Acute Toxicity Working Group subsequently organized this workshop in coordination with NICEATM, the European Centre for the Validation of Alternative Methods, and the Japanese Center for the Validation of Alternative Methods. The goals of the workshop are to:
(1)Review the state-of-the-science and identify knowledge gaps regarding the key pathways involved in acute systemic toxicity.
(2)Recommend how these knowledge gaps can be addressed by collecting mechanistic biomarker data during currently required *in vivo* safety testing.
(3)Recommend how key *in vivo* pathway information can be used to develop more predictive mechanism-based *in vitro* test systems and earlier more humane endpoints for *in vivo* test methods.
(4)Recommend how mechanism-based *in vitro* test systems and earlier, more humane endpoints can be used to further reduce, refine, and replace animal use for acute systemic toxicity testing while ensuring the protection of human health. Workshop Attendance and Registration The workshop will be held on February 6-7, 2008, at the NIH Natcher Conference Center, 45 Center Drive, Bethesda, MD 20892. Sessions will begin at 8 a.m. and end at approximately 5 p.m. on both days. Persons needing special assistance in order to attend, such as sign language interpretation or other reasonable accommodation, should contact 919-541-2475 voice, 919-541-4644 TTY (text telephone, through the Federal TTY Relay System at 800-877-8339), or e-mail *niehsoeeo@niehs.nih.gov* . Requests should be made at least seven days in advance of the event. This workshop is open to the public with attendance being limited only by the space available. Individuals who plan to attend are encouraged to register in advance with NICEATM. Registration information, an agenda, and additional information are available on the workshop Web site ( *http://iccvam.niehs.nih.gov/meetings/AcuteToxWksp08/AcuteToxWksp08.htm* ) and upon request to NICEATM (see FOR FURTHER INFORMATION CONTACT above). Preliminary Workshop Agenda Day 1—Wednesday, February 6, 2008 • Opening Plenary Session—Welcome and Overview of Workshop Objectives. • Session 1—Current Acute Systemic Toxicity Injury and Toxicity Assessments. • Session 2—Key Pathways and Biomarkers for Acute Systemic Toxicity. • Concurrent Breakout Group
(BG)Discussions: —BG 1: Acute Systemic Toxicity Injury and Toxicity Assessments. —BG 2: Key Pathways and Biomarkers for Acute Systemic Toxicity. • Adjournment. Day 2—Thursday, February 7, 2008 • Plenary Session—Discussion of Conclusions and Recommendations from Breakout Groups 1 and 2. • Session 3—Developing Earlier Humane Endpoints for Acute Systemic Toxicity. • Session 4—State of the Science: Using *In Vitro* Methods to Predict Acute Systemic Toxicity. • Concurrent BG Discussions: —BG 3: Developing Earlier Humane Endpoints for Acute Systemic Toxicity Testing. —BG 4: Applying *In Vivo* Mechanistic Pathway Information to the Development and Validation of *In Vitro* Methods for Assessing Acute Systemic Toxicity. —BG 5: Partnering with Industry to Advance Acute Toxicity Alternative Test Method Development, Validation, and Use. • Plenary Session—Discussion of Conclusions and Recommendations from Breakout Groups 3, 4, and 5. • Workshop Adjournment. Background Information on ICCVAM, NICEATM, and SACATM ICCVAM is an interagency committee composed of representatives from 15 Federal regulatory and research agencies that use, generate, or disseminate toxicological information. ICCVAM conducts technical evaluations of new, revised, and alternative methods with regulatory applicability and promotes the scientific validation and regulatory acceptance of toxicological test methods that more accurately assess the safety and hazards of chemicals and products and that refine, reduce, and replace animal use. The ICCVAM Authorization Act of 2000 (42 U.S.C. 285 *l* -3) established ICCVAM as a permanent interagency committee of the NIEHS under NICEATM. NICEATM administers ICCVAM and provides scientific and operational support for ICCVAM-related activities. NICEATM and ICCVAM work collaboratively to evaluate new and improved test methods applicable to the needs of Federal agencies. Additional information about ICCVAM and NICEATM can be found on their Web site ( *http://iccvam.niehs.nih.gov* ). SACATM was established January 9, 2002, and is composed of scientists from the public and private sectors ( **Federal Register** , Vol. 67, No. 49, page 11358, March 13, 2002). SACATM provides advice to the Director of the NIEHS, ICCVAM, and NICEATM regarding the statutorily mandated duties of ICCVAM and activities of NICEATM. Additional information about SACATM, including the charter, roster, and records of past meetings, can be found at *http://ntp.niehs.nih.gov/go/167.* Dated: December 19, 2007. Samuel H. Wilson, Acting Director, National Institute of Environmental Health Sciences and National Toxicology Program. [FR Doc. E7-25536 Filed 1-2-08; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Current List of Laboratories Which Meet Minimum Standards To Engage in Urine Drug Testing for Federal Agencies AGENCY: Substance Abuse and Mental Health Services Administration, HHS. ACTION: Notice. SUMMARY: The Department of Health and Human Services
(HHS)notifies Federal agencies of the laboratories currently certified to meet the standards of Subpart C of the Mandatory Guidelines for Federal Workplace Drug Testing Programs (Mandatory Guidelines). The Mandatory Guidelines were first published in the **Federal Register** on April 11, 1988 (53 FR 11970), and subsequently revised in the **Federal Register** on June 9, 1994 (59 FR 29908), on September 30, 1997 (62 FR 51118), and on April 13, 2004 (69 FR 19644). A notice listing all currently certified laboratories is published in the **Federal Register** during the first week of each month. If any laboratory's certification is suspended or revoked, the laboratory will be omitted from subsequent lists until such time as it is restored to full certification under the Mandatory Guidelines. If any laboratory has withdrawn from the HHS National Laboratory Certification Program
(NLCP)during the past month, it will be listed at the end, and will be omitted from the monthly listing thereafter. This notice is also available on the Internet at *http://www.workplace.samhsa.gov* and *http://www.drugfreeworkplace.gov* . FOR FURTHER INFORMATION CONTACT: Mrs. Giselle Hersh, Division of Workplace Programs, SAMHSA/CSAP, Room 2-1042, One Choke Cherry Road, Rockville, Maryland 20857; 240-276-2600 (voice), 240-276-2610 (fax). SUPPLEMENTARY INFORMATION: The Mandatory Guidelines were developed in accordance with Executive Order 12564 and section 503 of Pub. L. 100-71. Subpart C of the Mandatory Guidelines, “Certification of Laboratories Engaged in Urine Drug Testing for Federal Agencies,” sets strict standards that laboratories must meet in order to conduct drug and specimen validity tests on urine specimens for Federal agencies. To become certified, an applicant laboratory must undergo three rounds of performance testing plus an on-site inspection. To maintain that certification, a laboratory must participate in a quarterly performance testing program plus undergo periodic, on-site inspections. Laboratories which claim to be in the applicant stage of certification are not to be considered as meeting the minimum requirements described in the HHS Mandatory Guidelines. A laboratory must have its letter of certification from HHS/SAMHSA (formerly: HHS/NIDA) which attests that it has met minimum standards. In accordance with Subpart C of the Mandatory Guidelines dated April 13, 2004 (69 FR 19644), the following laboratories meet the minimum standards to conduct drug and specimen validity tests on urine specimens: ACL Laboratories, 8901 W. Lincoln Ave., West Allis, WI 53227, 414-328-7840/800-877-7016. ( *Formerly:* Bayshore Clinical Laboratory) ACM Medical Laboratory, Inc., 160 Elmgrove Park, Rochester, NY 14624, 585-429-2264. Advanced Toxicology Network, 3560 Air Center Cove, Suite 101, Memphis, TN 38118, 901-794-5770/888-290-1150. Aegis Sciences Corporation, 345 Hill Ave., Nashville, TN 37210, 615-255-2400. ( *Formerly:* Aegis Analytical Laboratories, Inc.) Baptist Medical Center—Toxicology Laboratory, 9601 I-630, Exit 7, Little Rock, AR 72205-7299, 501-202-2783. ( *Formerly:* Forensic Toxicology Laboratory Baptist Medical Center) Clinical Reference Lab, 8433 Quivira Road, Lenexa, KS 66215-2802, 800-445-6917. Diagnostic Services, Inc., dba DSI, 12700 Westlinks Drive, Fort Myers, FL 33913, 239-561-8200/800-735-5416. Doctors Laboratory, Inc., 2906 Julia Drive, Valdosta, GA 31602, 229-671-2281. DrugScan, Inc., P.O. Box 2969, 1119 Mearns Road, Warminster, PA 18974, 215-674-9310. Dynacare Kasper Medical Laboratories,* 10150-102 St., Suite 200, Edmonton, Alberta, Canada T5J 5E2, 780-451-3702/800-661-9876. ElSohly Laboratories, Inc., 5 Industrial Park Drive, Oxford, MS 38655, 662-236-2609. Gamma-Dynacare Medical Laboratories,* A Division of the Gamma-Dynacare Laboratory Partnership, 245 Pall Mall Street, London, ONT, Canada N6A 1P4, 519-679-1630. Kroll Laboratory Specialists, Inc., 1111 Newton St., Gretna, LA 70053, 504-361-8989/800-433-3823. ( *Formerly:* Laboratory Specialists, Inc.) Kroll Laboratory Specialists, Inc., 450 Southlake Blvd., Richmond, VA 23236, 804-378-9130. ( *Formerly:* Scientific Testing Laboratories, Inc.; Kroll Scientific Testing Laboratories, Inc.) Laboratory Corporation of America Holdings, 7207 N. Gessner Road, Houston, TX 77040, 713-856-8288/800-800-2387. Laboratory Corporation of America Holdings, 69 First Ave., Raritan, NJ 08869, 908-526-2400/800-437-4986. ( *Formerly:* Roche Biomedical Laboratories, Inc.) Laboratory Corporation of America Holdings, 1904 Alexander Drive, Research Triangle Park, NC 27709, 919-572-6900/800-833-3984. ( *Formerly:* LabCorp Occupational Testing Services, Inc., CompuChem Laboratories, Inc.; CompuChem Laboratories, Inc., A Subsidiary of Roche Biomedical Laboratory; Roche CompuChem Laboratories, Inc., A Member of the Roche Group) Laboratory Corporation of America Holdings, 13112 Evening Creek Drive, Suite 100, San Diego, CA 92128, 858-668-3710/800-882-7272. ( *Formerly:* Poisonlab, Inc.). Laboratory Corporation of America Holdings, 550 17th Ave., Suite 300, Seattle, WA 98122, 206-923-7020/800-898-0180. ( *Formerly:* DrugProof, Division of Dynacare/Laboratory of Pathology, LLC; Laboratory of Pathology of Seattle, Inc.; DrugProof, Division of Laboratory of Pathology of Seattle, Inc.) Laboratory Corporation of America Holdings, 1120 Main Street, Southaven, MS 38671, 866-827-8042/800-233-6339. ( *Formerly:* LabCorp Occupational Testing Services, Inc.; MedExpress/National Laboratory Center) LabOne, Inc. d/b/a Quest Diagnostics, 10101 Renner Blvd., Lenexa, KS 66219, 913-888-3927/800-873-8845. ( *Formerly:* Quest Diagnostics Incorporated; LabOne, Inc.; Center for Laboratory Services, a Division of LabOne, Inc.,) MAXXAM Analytics Inc.,* 6740 Campobello Road, Mississauga, ON, Canada L5N 2L8, 905-817-5700. ( *Formerly:* NOVAMANN (Ontario), Inc.) MedTox Laboratories, Inc., 402 W. County Road D, St. Paul, MN 55112, 651-636-7466/800-832-3244. MetroLab-Legacy Laboratory Services, 1225 NE 2nd Ave., Portland, OR 97232, 503-413-5295/800-950-5295. Minneapolis Veterans Affairs Medical Center, Forensic Toxicology Laboratory, 1 Veterans Drive, Minneapolis, MN 55417, 612-725-2088. National Toxicology Laboratories, Inc., 1100 California Ave., Bakersfield, CA 93304, 661-322-4250/800-350-3515. One Source Toxicology Laboratory, Inc., 1213 Genoa-Red Bluff, Pasadena, TX 77504, 888-747-3774. ( *Formerly:* University of Texas Medical Branch, Clinical Chemistry Division; UTMB Pathology-Toxicology Laboratory) Oregon Medical Laboratories, 123 International Way, Springfield, OR 97477, 541-341-8092. Pacific Toxicology Laboratories, 9348 DeSoto Ave., Chatsworth, CA 91311, 800-328-6942. ( *Formerly:* Centinela Hospital Airport Toxicology Laboratory) Pathology Associates Medical Laboratories, 110 West Cliff Dr., Spokane, WA 99204, 509-755-8991/800-541-7891x7. Phamatech, Inc., 10151 Barnes Canyon Road, San Diego, CA 92121, 858-643-5555. Quest Diagnostics Incorporated, 3175 Presidential Dr., Atlanta, GA 30340, 770-452-1590/800-729-6432. ( *Formerly:* SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 400 Egypt Road, Norristown, PA 19403, 610-631-4600/877-642-2216. ( *Formerly:* SmithKline Beecham Clinical Laboratories; SmithKline Bio-Science Laboratories) Quest Diagnostics Incorporated, 7600 Tyrone Ave., Van Nuys, CA 91405, 866-370-6699 / 818-989-2521. ( *Formerly:* SmithKline Beecham Clinical Laboratories) S.E.D. Medical Laboratories, 5601 Office Blvd., Albuquerque, NM 87109, 505-727-6300 / 800-999-5227. South Bend Medical Foundation, Inc., 530 N. Lafayette Blvd., South Bend, IN 46601, 574-234-4176 x276. Southwest Laboratories, 4645 E. Cotton Center Boulevard, Suite 177, Phoenix, AZ 85040, 602-438-8507/800-279-0027. Sparrow Health System, Toxicology Testing Center, St. Lawrence Campus, 1210 W. Saginaw, Lansing, MI 48915, 517-364-7400. ( *Formerly:* St. Lawrence Hospital & Healthcare System) St. Anthony Hospital Toxicology Laboratory, 1000 N. Lee St., Oklahoma City, OK 73101, 405-272-7052. Toxicology & Drug Monitoring Laboratory, University of Missouri Hospital & Clinics, 301 Business Loop 70 West, Suite 208, Columbia, MO 65203, 573-882-1273. Toxicology Testing Service, Inc., 5426 NW. 79th Ave., Miami, FL 33166, 305-593-2260. U.S. Army Forensic Toxicology Drug Testing Laboratory, 2490 Wilson St., Fort George G. Meade, MD 20755-5235, 301-677-7085. *The following laboratory will be voluntarily withdrawing from the HHS National Laboratory Certification Program on January 15, 2008:* Physicians Reference Laboratory, 7800 West 110th St., Overland Park, KS 66210, 913-339-0372/800-821-3627. *The Standards Council of Canada
(SCC)voted to end its Laboratory Accreditation Program for Substance Abuse (LAPSA) effective May 12, 1998. Laboratories certified through that program were accredited to conduct forensic urine drug testing as required by U.S. Department of Transportation
(DOT)regulations. As of that date, the certification of those accredited Canadian laboratories will continue under DOT authority. The responsibility for conducting quarterly performance testing plus periodic on-site inspections of those LAPSA-accredited laboratories was transferred to the U.S. HHS, with the HHS' NLCP contractor continuing to have an active role in the performance testing and laboratory inspection processes. Other Canadian laboratories wishing to be considered for the NLCP may apply directly to the NLCP contractor just as U.S. laboratories do. Upon finding a Canadian laboratory to be qualified, HHS will recommend that DOT certify the laboratory ( **Federal Register** , July 16, 1996) as meeting the minimum standards of the Mandatory Guidelines published in the **Federal Register** on April 13, 2004 (69 FR 19644). After receiving DOT certification, the laboratory will be included in the monthly list of HHS-certified laboratories and participate in the NLCP certification maintenance program. Elaine Parry, Acting Director, Office of Program Services, SAMHSA. [FR Doc. E7-25565 Filed 1-2-08; 8:45 am] BILLING CODE 4160-20-P DEPARTMENT OF HOMELAND SECURITY Transportation Security Administration [Docket Nos. TSA-2006-24191; Coast Guard-2006-24196] Transportation Worker Identification Credential (TWIC); Enrollment Dates for the Ports of Portland, OR; Victoria, TX; Kahului, Maui, HI; and Kauai, HI AGENCY: Transportation Security Administration; United States Coast Guard; DHS. ACTION: Notice. SUMMARY: The Department of Homeland Security
(DHS)through the Transportation Security Administration
(TSA)issues this notice of the dates for the beginning of the initial enrollment for the Transportation Worker Identification Credential
(TWIC)for the Ports of Portland, OR; Victoria, TX; Kahului, Maui, HI; and Kauai, HI. DATES: TWIC enrollment in Portland, OR, will begin on January 17, 2008; Victoria, TX, January 16, 2008; Kahului, Maui, HI, January 17, 2008; and Kauai, HI, January 25, 2008. ADDRESSES: You may view published documents and comments concerning the TWIC Final Rule, identified by the docket numbers of this notice, using any one of the following methods.
(1)Searching the Federal Docket Management System
(FDMS)Web page at *http://www.regulations.gov* ;
(2)Accessing the Government Printing Office's Web page at *http://www.gpoaccess.gov/fr/index.html* ; or
(3)Visiting TSA's Security Regulations Web page at *http://www.tsa.gov* and accessing the link for “Research Center” at the top of the page. FOR FURTHER INFORMATION CONTACT: James Orgill, TSA-19, Transportation Security Administration, 601 South 12th Street, Arlington, VA 22202-4220. Transportation Threat Assessment and Credentialing (TTAC), TWIC Program,
(571)227-4545; e-mail: *credentialing@dhs.gov* . Background The Department of Homeland Security (DHS), through the United States Coast Guard and the Transportation Security Administration (TSA), issued a joint final rule (72 FR 3492; January 25, 2007) pursuant to the Maritime Transportation Security Act (MTSA), Pub. L. 107-295, 116 Stat. 2064 (November 25, 2002), and the Security and Accountability for Every Port Act of 2006 (SAFE Port Act), Pub. L. 109-347 (October 13, 2006). This rule requires all credentialed merchant mariners and individuals with unescorted access to secure areas of a regulated facility or vessel to obtain a TWIC. In this final rule, on page 3510, TSA and Coast Guard stated that a phased enrollment approach based upon risk assessment and cost/benefit would be used to implement the program nationwide, and that TSA would publish a notice in the **Federal Register** indicating when enrollment at a specific location will begin and when it is expected to terminate. This notice provides the start date for TWIC initial enrollment at the Ports of Portland, OR; Victoria, TX; Kahului, Maui, HI; and Kauai, HI. Enrollment in Portland, OR will begin on January 17, 2008; Victoria, TX on January 16, 2008; Kahului, Maui, HI on January 17, 2008; and Kauai, HI on January 25, 2008. The Coast Guard will publish a separate notice in the **Federal Register** indicating when facilities within the Captain of the Port Zone Portland, including those in the Port of Portland; Captain of the Port Zone Corpus Christi, including those in the Port of Victoria; and Captain of the Port Zone Honolulu, including those in the Ports of Kahului, Maui and Kauai must comply with the portions of the final rule requiring TWIC to be used as an access control measure. That notice will be published at least 90 days before compliance is required. To obtain information on the pre-enrollment and enrollment process, and enrollment locations, visit TSA's TWIC Web site at *http://www.tsa.gov/twic* . Issued in Arlington, Virginia, on December 27, 2007. Rex Lovelady, Program Manager, TWIC, Office of Transportation Threat Assessment and Credentialing, Transportation Security Administration. [FR Doc. E7-25590 Filed 1-2-08; 8:45 am] BILLING CODE 9110-05-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [CO-921-03-1320-EL; COC-072069] Notice of Invitation for Coal Exploration License Application, Bowie Resources, LLC. COC-072069; Colorado AGENCY: Bureau of Land Management, Interior. ACTION: Notice of Invitation for Coal Exploration License. SUMMARY: Pursuant to section 2(b) of the Mineral Leasing Act of 1920, as amended, by section 4 of the Federal Coal Leasing Amendments Act of 1976, Stat. 1083, 30 U.S.C. 201(b), and to the regulations adopted as 43 Code of Federal Regulations (CFR), part 3410, all interested parties are hereby invited to participate with Bowie Resources, LLC, on a pro rata cost sharing basis in a program for the exploration of unleased coal deposits owned by the United States of America in Delta County, Colorado: T 12 S, R 91, 6th P.M. in Delta County, Colorado. Sec. 29, S2; Sec. 31, S2; Lots 7-26; Sec. 32, All; Sec. 33, W2NW; and T 12 S, R 92 W Sec. 35, All; Sec. 36, All. Containing 3,381 acres. DATES: Any party electing to participate in this exploration program must send written notice to both the Bureau of Land Management
(BLM)and Bowie Resources, LLC, as provided in the ADDRESSES section below, no later than 30 days after publication of this invitation in the **Federal Register** . ADDRESSES: Copies of the exploration plan and license application (serialized under the number of COC-072069) are available for review during normal business hours in the public room of the BLM State Office, 2850 Youngfield Street, Lakewood, Colorado 80215, and at the Uncompahgre Field Office, 2505 South Townsend Avenue, Montrose, Colorado 81401. The written notice to participate in the exploration plan should be sent to both, Kurt M. Barton, CO-921, Solid Minerals Staff, Division of Energy, Lands and Minerals, Colorado State Office, Bureau of Land Management, 2850 Youngfield Street, Lakewood, Colorado 80215; and, Collin Stewart, Bowie Resources, LLC, PO Box 483, Paonia, CO 81428. SUPPLEMENTARY INFORMATION: This coal exploration license will be issued by the BLM. The exploration program is fully described and is being conducted pursuant to an exploration plan approved by the BLM. The plan may be modified to accommodate the legitimate exploration needs of persons seeking to participate. This notice of invitation to participate was published in The Delta County Independent, once a week for two consecutive weeks beginning the first week of December 2007 and in the **Federal Register** . The forgoing is published in the **Federal Register** pursuant to 43 CFR 3410.2-1(c)(1). Kurt M. Barton, Solid Minerals Staff, Division of Energy, Lands and Minerals. [FR Doc. E7-25586 Filed 1-2-08; 8:45 am] BILLING CODE 4310-JB-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [OR-957-00-6334-BJ: GP08-035] Filing of Plats of Survey: Oregon/Washington AGENCY: U.S. Department of the Interior, Bureau of Land Management. ACTION: Notice. SUMMARY: The plats of survey of the following described lands were officially filed in the Bureau of Land Management Oregon/Washington State Office, Portland, Oregon, on September 13, 2007. Willamette Meridian Washington T. 23 N., R. 13 W., accepted July 12, 2007. T. 21 N., R. 12 W., accepted July 19, 2007. T. 21 N., R. 13 W., accepted August 17, 2007. Oregon T. 18 S., R. 34 E., accepted July 12, 2007. T. 41 S., R. 7 E., accepted July 30, 2007. T. 39 S., R. 3 W., accepted August 17, 2007. T. 8 S., R. 3 E., accepted August 17, 2007. The plats of survey of the following described lands were officially filed in the Bureau of Land Management Oregon/Washington State Office, Portland, Oregon, on October 22, 2007. Willamette Meridian Washington T. 39 N., R. 33 E., accepted August 31, 2007. T. 30 N., R. 7 W., accepted September 28, 2007. Oregon T. 31 S., R. 2 W., accepted September 13, 2007. T. 41 S., R. 9 W., accepted September 28, 2007. T. 36 S., R. 7 W., accepted September 28, 2007. T. 8 S., R. 27 E., accepted September 28, 2007. The plat of survey of the following described lands was officially filed in the Bureau of Land Management Oregon/Washington State Office, Portland, Oregon, on November 6, 2007. Willamette Meridian Oregon T. 32 S., R. 4 W., accepted October 18, 2007. A copy of the plats may be obtained from the Land Office at the Oregon/Washington State Office, Bureau of Land Management, 333 SW. 1st Avenue, Portland, Oregon 97204, upon required payment. A person or party who wishes to protest against a survey must file a notice that they wish to protest (at the above address) with the Oregon/Washington State Director, Bureau of Land Management, Portland, Oregon. For further information contact: Chief, Branch of Geographic Sciences, Bureau of Land Management, (333 SW. 1st Avenue) P.O. Box 2965, Portland, Oregon 97208. Dated: December 13, 2007. Fred O'Ferrall, Branch Chief, Lands and Minerals Resources. [FR Doc. E7-25430 Filed 1-2-08; 8:45 am] BILLING CODE 4310-33-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [ID 100 1220MA 241A: DBG081014] Notice of Public Meeting: Resource Advisory Council to the Boise District, Bureau of Land Management, U.S. Department of the Interior AGENCY: Bureau of Land Management, U.S. Department of the Interior. ACTION: Notice of Public Meeting. SUMMARY: In accordance with the Federal Land Policy and Management Act (FLPMA) and the Federal Advisory Committee Act of 1972 (FACA), the U.S. Department of the Interior, Bureau of Land Management
(BLM)Boise District Resource Advisory Council (RAC), will hold a meeting as indicated below. DATES: The meeting will be held January 31, 2008, beginning at 9 a.m. and adjourning at 3 p.m. The meeting will be held at the Boise District Office located at 3948 S. Development Avenue, Boise Idaho. Public comment periods will be held during the course of the meeting. FOR FURTHER INFORMATION CONTACT: MJ Byrne, Public Affairs Officer and RAC Coordinator, BLM Boise District, 3948 Development Ave., Boise, ID 83705, Telephone
(208)384-3393. SUPPLEMENTARY INFORMATION: The 15-member Council advises the Secretary of the Interior, through the BLM, on a variety of planning and management issues associated with public land management in southwestern Idaho. The Council will be briefed by a representative of Idaho's U.S. Senator Mike Crapo's office regarding the Fee Repeal and Expanded Access Act of 2007 that he is a co-sponsor of with Montana's U.S. Senator Mike Baucus. The bill would repeal the 2004 passed Federal Lands Recreation Enhancement Act. There will be a discussion about the West-Wide Energy Corridor Programmatic Environmental Impact Statement and proposed routes going through the District's public lands. Hot Topics will be discussed by the District Manager and Field Office managers will provide highlights on activities in their offices. Agenda items and location may change due to changing circumstances. All meetings are open to the public. The public may present written comments to the Council. Each formal Council meeting will also have time allocated for hearing public comments. Depending on the number of persons wishing to comment and time available, the time for individual oral comments may be limited. Individuals who plan to attend and need special assistance, such as sign language interpretation, or other reasonable accommodations, should contact the BLM Coordinator as provided above. Dated: December 27, 2007. David Wolf, Associate, District Manager. [FR Doc. E7-25547 Filed 1-2-08; 8:45 am] BILLING CODE 4310-GG-P DEPARTMENT OF THE INTERIOR Bureau of Land Management [NV-030-7122-EU; N-79995; 8-08807; TAS: 14X8069] Notice of Realty Action: Non-Competitive (Direct) Sale of Public Land in Mineral County, NV AGENCY: Bureau of Land Management, Interior. ACTION: Notice of Realty Action. SUMMARY: The Bureau of Land Management
(BLM)proposes to sell approximately 425 acres of public land within and adjacent to the Denton-Rawhide Mine in Mineral County, Nevada. The sale will be made under the provisions of Section 203 of the Federal Land Policy and Management Act (FLPMA), (43 U.S.C. 1713). DATES: Interested parties may submit written comments regarding the proposed conveyance of the public land until February 19, 2008. ADDRESSES: Mail written comments to the BLM Field Manager, Carson City Field Office, 5665 Morgan Mill Road, Carson City, NV 89701. FOR FURTHER INFORMATION CONTACT: Jo Ann Hufnagle,
(775)885-6000. SUPPLEMENTARY INFORMATION: On August 1, 2007, the BLM Nevada State Director approved the Final Denton-Rawhide Mine Land Sale Plan Amendment to the Carson City Consolidated Resource Management Plan, which identified the following described public land for disposal and found the land suitable for transfer out of Federal ownership by direct sale under the authority of Sections 203 and 209 of the Federal Land Policy and Management Act of 1976, as amended (43 U.S.C. 1713 and 1719): Mount Diablo Meridian, Nevada T. 13 N., R. 32 E. Sec. 4, lots 6, 7, 8, and 9; Sec. 5, lots 3, 4, 6, 7, 8, 9, 10, 11, 12, and 13 (eastern portions only of lots 4, 6, 10, and 11); Sec. 8, lots 1, 2, 4, 5, 6, and 7; Sec. 9, lots 1, 2, 3, 4, 5, 6, 7, and 8 (western portions only of lots 1, 4, 5 and 8). The area described contains 425 acres, more or less. Note: This description may be modified prior to sale upon final approval of official plats of survey which will involve amended lottings of portions of the public land. A map depicting the sale land is available for review at the Carson City Field Office. On January 3, 2008, the above-described land is hereby segregated from appropriation under the public land laws, including the mining and mineral laws, except the sale provisions of FLPMA. Upon publication of this Notice of Realty Action and until completion of the sale, the BLM is no longer accepting land use applications affecting the identified public land, except applications for the amendment of previously filed right-of-way applications or existing authorizations to increase the term of the grants in accordance with 43 CFR 2807.15 and 2886.15. The segregative effect will terminate upon issuance of a patent, publication in the **Federal Register** of a termination of the segregation, or on January 4, 2010, unless extended by the BLM Nevada State Director in accordance with 43 CFR 2711.1-2(d) prior to the termination date. The public land is proposed for sale to Kennecott Rawhide Mining Company
(KRMC)at not less than the appraised fair market value, currently determined to be $32,000. KRMC owns 758 acres of land that surround or adjoin the public land proposed for sale and holds mining claims on all public land proposed for sale. The mining claims would be relinquished as a condition for conveyance. Use of the public land could be achieved prudently in conjunction with fee land owned by KRMC. Disposal of the lands to KRMC would serve important public objectives because its location is difficult and uneconomic to manage as part of the public lands. A mineral potential evaluation was completed for public land within the sale area and no known mineral values were identified. Agreement to purchase the land will constitute an application for conveyance of the mineral estate, in accordance with Section 209 of FLPMA. The designated buyer must include with their purchase payment a nonrefundable $50 filing fee for the conveyance of the mineral estate. The conveyance, when issued, will be subject to the provisions of FLPMA and applicable regulations of the Secretary of the Interior, and will contain as a reservation to the United States a right-of-way for ditches and canals reserved by the United States under the Act of August 30, 1890 (43 U.S.C. 945). The conveyance would be subject to the following numbered terms and conditions in the patent to be issued: 1. Valid existing rights; and, 2. The purchaser/patentee, by accepting patent, agrees to indemnify, defend, and hold the United States harmless from any costs, damages, claims, causes of action, penalties, fines, liabilities, and judgments of any kind arising from the past, present or future acts or omissions of the patentee, its employees, agents, contractors, or lessees, or any third-party arising out of or in connection with the patentee's use and/or occupancy of the patented real property resulting in:
(1)Violations of Federal, State, and local laws and regulations that are now or in the future become, applicable to the real property;
(2)Judgments, claims or demands of any kind assessed against the United States;
(3)Costs, expenses, or damages of any kind incurred by the United States;
(4)Releases or threatened releases of solid or hazardous waste(s) and/or hazardous substances(s), as defined by Federal or State environmental laws, off, on, into or under land, property, and other interests of the United States;
(5)Other activities by which solids or hazardous substances or wastes, as defined by Federal and State environmental laws are generated, released, stored, used, or otherwise disposed of on the patented real property, and any cleanup response, remedial action or other actions related in any manner to said solid or hazardous substances or wastes; or
(6)Natural resource damages as defined by Federal and State law. This covenant shall be construed as running with the patented real property and may be enforced by the United States in a court of competent jurisdiction. The approved appraisal report, maps, Resource Management Plan Amendment, Environmental Assessment, and other supporting documentation are available for review at the Carson City Field Office. The public land will not be offered for sale until at least 60 days after publication of this notice of realty action. For a period until February 19, 2008, interested parties may submit written comments to the Carson City Field Office. Before including your address, phone number, e-mail address, or other personal identifying information in your comment, you should be aware that your entire comment—including your personal identifying information—may be made publicly available at any time. While you can ask us in your comment to withhold your personal identifying information from public review, we cannot guarantee that we will be able to do so. Only written comments submitted by postal service or overnight mail to the Field Manager, BLM Carson City Field Office, will be considered properly filed. Electronic mail, facsimile, or telephone comments will not be considered properly filed. Any adverse comments will be reviewed by the BLM Nevada State Director, who may sustain, vacate, or modify this realty action. In the absence of any adverse comments, this realty action will become the final determination of the Department of the Interior. (Authority: 43 CFR 2711.1-2) Dated: December 27, 2007. Donald T. Hicks, Carson City Field Manager. [FR Doc. E7-25560 Filed 1-2-08; 8:45 am] BILLING CODE 4310-HC-P DEPARTMENT OF THE INTERIOR National Park Service National Register of Historic Places; Notification of Pending Nominations and Related Actions Nominations for the following properties being considered for listing or related actions in the National Register were received by the National Park Service before December 15, 2007. Pursuant to section 60.13 of 36 CFR Part 60 written comments concerning the significance of these properties under the National Register criteria for evaluation may be forwarded by United States Postal Service, to the National Register of Historic Places, National Park Service, 1849 C St., NW., 2280, Washington, DC 20240; by all other carriers, National Register of Historic Places, National Park Service, 1201 Eye St., NW., 8th floor, Washington, DC 20005; or by fax, 202-371-6447. Written or faxed comments should be submitted by January 18, 2008. J. Paul Loether, Chief, National Register of Historic Places/National Historic Landmarks Program. ARKANSAS Carroll County U.S. 62 White River Bridge, (Historic Bridges of Arkansas MPS) U.S. 62 approx. 1/4 mi. S. of Co. Rd. 212, Eureka Springs, 07001421 Craighead County Community Center #1, (New Deal Recovery Efforts in Arkansas MPS) 1212 S. Church St., Jonesboro, 07001422 First National Bank Building, 207 W. Drew Ave., Monette, 07001423 Monette Water Tower, (New Deal Recovery Efforts in Arkansas MPS) SW. corner jct. of AR 139 & Texie Ave., Monette, 07001424 Dallas County Tennessee, Alabama & Georgia Railway Steam Locomotive #101, NW. of jct. of N. Main St. & Union Pacific RR., Fordyce, 07001425 Desha County Mound Cemetery, .5 mi. N. of Arkansas City on Co. Rd. 351, Arkansas City, 07001426 Drew County Look See Tree, SW. corner jct. of AR 83 & Pleasant Springs Rd., Coleman, 07001427 Little River County Texarkana and Fort Smith Railway Depot, (Historic Railroad Depots of Arkansas MPS) Texarkana Ave., Wilton, 07001428 Logan County Little Rock to Cantonment Gibson Road—Short Mountain Segment, Short Mt. Rd. between Horseshoe Mt. and Short Mt. Cr., Paris, 07001429 Madison County War Eagle Creek Bridge, (Historic Bridges of Arkansas MPS) Co. Rd. 53 over War Eagle Cr., Old Alabam, 07001430 Pulaski County Parnell Hall, 2400 W. Markham, Little Rock, 07001431 Roundtop Filling Station, (Arkansas Highway History and Architecture MPS) Jct. Trammel & Roundtop Rds., Sherwood, 07001432 Randolph County Marr's Creek Bridge, (Historic Bridges of Arkansas MPS) S. Bettis St., Pocahontas, 07001433 Sebastian County Hartford Water Tower, (New Deal Recovery Efforts in Arkansas MPS) Pine & 1st Sts., Hartford, 07001434 Union County Murphy, J.T., No 1 Crater, Firetower Rd., 3/4 mi. N. of jct. with Baugh St., Norphlet, 07001435 Washington County Evansville—Dutch Mills Road Bridge, (Historic Bridges of Arkansas MPS) Co. Rd. 464, Dutch Mills, 07001436 White River Bridge at Elkins, (Historic Bridges of Arkansas MPS) Co. Rd. 44, Elkins, 07001437 Yell County Old Arkansas 22—Dardanelle Segment, (Arkansas Highway History and Architecture MPS) Co. Rd. 906, 1/2 mi. W. of jct. AR 22 and Co. Rd. 51, Dardanelle, 07001438 CALIFORNIA Los Angeles County Board of Trade Building, 111 W. 7th St., Los Angeles, 07001439 CONNECTICUT Fairfield County Greenfield Hill Grange #133, 1873 Hillside Rd., Fairfield, 07001440 Silvermine Center Historic District, Roughly centered on Silvermine & Perry Aves., Norwalk, 07001441 MAINE Hancock County Hancock County Jail, 40 State St., Ellsworth, 07001445 Oxford County Deering Memorial United Methodist Church, 39 Main St., Paris, 07001444 Penobscot County Corinth Town Hall and Corinthian Lodge #59, I.O.O.F., 328 Main St., Corinth, 07001446 Enterprise Grange, No. 173, 446 Dow Rd., Orrington, 07001447 York County Goodall, Louis B., Memorial Library, (Maine Public Libraries MPS) 952 Main St., Sanford, 07001448 Rock Rest, 167 Brave Boat Harbor Rd., Kittery, 07001449 MARYLAND Frederick County L'Hermitage Slave Village Archeological Site, Address Restricted, Frederick, 07001450 NEW YORK Broome County Binghamton Theatre, 236 Washington St., Binghamton, 07001451 Livingston County Barber, Aaron, Memorial Building, 143 Genesee St., Avon, 07001452 Nassau County House at 251 Rocklyn Ave., 251 Rocklyn Ave., Lynbrook, 07001454 House at 474 Ocean Avenue, 474 Ocean Ave., Lynbrook, 07001455 House at 73 Grove Street, 73 Grove St., Lynbrook, 07001456 Suffolk County Davis Field, 2nd St., & 3rd Ave., Bayport, 07001456 WASHINGTON King County Palmer, A.L., Building, 1000 1st. Ave. S., Seattle, 07001457 Pierce County Auditorium Dance Hall, The, 1308-1310 Fawcett Ave., Tacoma, 07001458 Beutel, Conrad F. & Annie K., House, 701 N. 10th St., Tacoma, 07001459 WISCONSIN Dane County Orpheum Theatre, 216 State St., Madison, 07001460 Kewaunee County Perry, Melvin W. and Mary, House, 519 3rd St., Algoma, 07001461 A request to MOVE has been made for the following resource: NEW YORK New York County Hamilton Grange National Memorial, 287 Convent Ave., New York, 66000097 A request for REMOVAL has been made for the following resources: ARKANSAS Ashley County Greenview Café, 3rd Ave. and Arkansas St., Crossett, 04001507 Hempstead County Carrigan House 704 W. Ave. B., Hope, 78000591 Independence County Locust Grove School, AR 230 S. of jct. with AR 25, Locust Grove, 92001107 Jefferson County Collier House, 1227 W. 5th St., Pine Bluff, 82000824 Lonoke County St. Louis Southwestern Railway (Cotton Belt Route) Depot, Main St., Coy, 03001459 [FR Doc. 07-6277 Filed 1-2-08; 8:45 am]
Connectionstraces to 11
Traces to 11 documents
U.S. Code
register
9 references not yet in our index
- 12 CFR 225
- Pub. L. 100-71
- Pub. L. 107-295
- Pub. L. 109-347
- 43 CFR 3410.2-1(c)(1)
- 43 CFR 2807.15
- 43 CFR 2711.1-2(d)
- 43 CFR 2711.1-2
- 36 CFR 60
Citation graph
cites case law
Notices
Workshop announcement
Cite12 CFR 225
Pub. L.Pub. L. 100-71
Pub. L.Pub. L. 107-295
Cites 20 · showing 12Cited by 0 across 0 sources